Omron's Industrial Automation and Healthcare businesses continue to drive upward revisions in OP guidance but with margins already at high levels upside levers to justify valuations are limited.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.